CN103622121A - 一种含丙谷二肽的固体饮品 - Google Patents
一种含丙谷二肽的固体饮品 Download PDFInfo
- Publication number
- CN103622121A CN103622121A CN201310565995.1A CN201310565995A CN103622121A CN 103622121 A CN103622121 A CN 103622121A CN 201310565995 A CN201310565995 A CN 201310565995A CN 103622121 A CN103622121 A CN 103622121A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- glutamine
- milligrams
- solid beverage
- beverage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 28
- 239000007787 solid Substances 0.000 title claims abstract description 14
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 title abstract 3
- 108010044940 alanylglutamine Proteins 0.000 title abstract 3
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims abstract description 26
- 235000003599 food sweetener Nutrition 0.000 claims abstract description 22
- 239000003765 sweetening agent Substances 0.000 claims abstract description 22
- 239000002994 raw material Substances 0.000 claims abstract description 19
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 18
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 16
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 13
- 229930006000 Sucrose Natural products 0.000 claims abstract description 13
- 239000001103 potassium chloride Substances 0.000 claims abstract description 13
- 235000011164 potassium chloride Nutrition 0.000 claims abstract description 13
- 239000005720 sucrose Substances 0.000 claims abstract description 13
- GGTYBZJRPHEQDG-WCCKRBBISA-N (2s)-2,5-diaminopentanoic acid hydrochloride Chemical compound Cl.NCCC[C@H](N)C(O)=O GGTYBZJRPHEQDG-WCCKRBBISA-N 0.000 claims abstract description 12
- UYUXSRADSPPKRZ-SKNVOMKLSA-N D-glucurono-6,3-lactone Chemical compound O=C[C@H](O)[C@H]1OC(=O)[C@@H](O)[C@H]1O UYUXSRADSPPKRZ-SKNVOMKLSA-N 0.000 claims abstract description 9
- 229950002441 glucurolactone Drugs 0.000 claims abstract description 9
- 229960003080 taurine Drugs 0.000 claims abstract description 9
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 8
- 229960003244 ornithine hydrochloride Drugs 0.000 claims abstract description 8
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract description 8
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 8
- 239000011718 vitamin C Substances 0.000 claims abstract description 8
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims abstract description 6
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 claims abstract description 4
- 229930003537 Vitamin B3 Natural products 0.000 claims abstract description 4
- 229960003512 nicotinic acid Drugs 0.000 claims abstract description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinic acid amide Natural products NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims abstract description 4
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract description 4
- 235000019160 vitamin B3 Nutrition 0.000 claims abstract description 4
- 239000011708 vitamin B3 Substances 0.000 claims abstract description 4
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract description 4
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 4
- 229940011671 vitamin b6 Drugs 0.000 claims abstract description 4
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims description 32
- 108010016626 Dipeptides Proteins 0.000 claims description 26
- 239000004475 Arginine Substances 0.000 claims description 12
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 12
- 239000000463 material Substances 0.000 claims description 9
- -1 0.15~0.3 part Chemical compound 0.000 claims description 7
- 108010011485 Aspartame Proteins 0.000 claims description 7
- 239000000605 aspartame Substances 0.000 claims description 7
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical group OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 7
- 229960003438 aspartame Drugs 0.000 claims description 7
- 235000010357 aspartame Nutrition 0.000 claims description 7
- CEYULKASIQJZGP-UHFFFAOYSA-L disodium;2-(carboxymethyl)-2-hydroxybutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)CC(O)(C(=O)O)CC([O-])=O CEYULKASIQJZGP-UHFFFAOYSA-L 0.000 claims description 7
- 239000000796 flavoring agent Substances 0.000 claims description 2
- 235000019634 flavors Nutrition 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 abstract description 24
- 235000013343 vitamin Nutrition 0.000 abstract description 24
- 239000011782 vitamin Substances 0.000 abstract description 24
- 229940088594 vitamin Drugs 0.000 abstract description 24
- 230000006870 function Effects 0.000 abstract description 7
- 150000001413 amino acids Chemical class 0.000 abstract description 6
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 abstract description 3
- 239000000654 additive Substances 0.000 abstract description 3
- 210000004556 brain Anatomy 0.000 abstract description 3
- 235000020510 functional beverage Nutrition 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 3
- 239000013589 supplement Substances 0.000 abstract description 3
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 abstract 4
- 229940090949 docosahexaenoic acid Drugs 0.000 abstract 2
- 235000020669 docosahexaenoic acid Nutrition 0.000 abstract 2
- SUUWYOYAXFUOLX-ZBRNBAAYSA-N (2s)-2-aminobutanedioic acid;(2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O.OC(=O)[C@@H](N)CCCN=C(N)N SUUWYOYAXFUOLX-ZBRNBAAYSA-N 0.000 abstract 1
- UYUXSRADSPPKRZ-UHFFFAOYSA-N D-glucuronic acid gamma-lactone Natural products O=CC(O)C1OC(=O)C(O)C1O UYUXSRADSPPKRZ-UHFFFAOYSA-N 0.000 abstract 1
- 229930003779 Vitamin B12 Natural products 0.000 abstract 1
- 229940024606 amino acid Drugs 0.000 abstract 1
- 229960002223 arginine aspartate Drugs 0.000 abstract 1
- 229960005337 lysine hydrochloride Drugs 0.000 abstract 1
- 229960002816 potassium chloride Drugs 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 239000001509 sodium citrate Substances 0.000 abstract 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 abstract 1
- 229960001790 sodium citrate Drugs 0.000 abstract 1
- 235000011083 sodium citrates Nutrition 0.000 abstract 1
- 229960004793 sucrose Drugs 0.000 abstract 1
- 235000019163 vitamin B12 Nutrition 0.000 abstract 1
- 239000011715 vitamin B12 Substances 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 230000035622 drinking Effects 0.000 description 10
- 244000269722 Thea sinensis Species 0.000 description 8
- 235000009569 green tea Nutrition 0.000 description 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- 235000015203 fruit juice Nutrition 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 238000004080 punching Methods 0.000 description 5
- 238000003756 stirring Methods 0.000 description 5
- 230000003712 anti-aging effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 230000008014 freezing Effects 0.000 description 4
- 238000007710 freezing Methods 0.000 description 4
- 230000002929 anti-fatigue Effects 0.000 description 3
- 235000019987 cider Nutrition 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000001537 neural effect Effects 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 208000019914 Mental Fatigue Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 229940010007 cobalamins Drugs 0.000 description 2
- 150000001867 cobalamins Chemical class 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000003340 mental effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010049976 Impatience Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 1
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000004872 arterial blood pressure Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000000750 endocrine system Anatomy 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182480 glucuronide Natural products 0.000 description 1
- 150000008134 glucuronides Chemical class 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000005891 transamination reaction Methods 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Non-Alcoholic Beverages (AREA)
- Tea And Coffee (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了一种含丙谷二肽的固体饮品，原料包括以下物质：丙谷二肽、蔗糖、牛磺酸、精氨酸门冬氨酸、赖氨酸盐酸盐、鸟氨酸盐酸盐、维生素B3、维生素B6、维生素C、维生素B12、柠檬酸钠、葡萄糖醛酸内酯、氯化钾、DHA、甜味剂。本发明固体饮品能够补充能量、提高精力、抗衰老、抗疲劳，由氨基酸类、维生素类、添加剂类、微量元素等成分构成，是一种用于调节人体机能的功能性饮品制剂；适合旅游爱好者、运动员、体力劳动和脑力劳动者饮用。
Description
技术领域
本发明涉及固体饮品技术领域。
背景技术
随着社会经济的发展，人们工作压力越来越大，随之而来的情绪失衡、精神疲劳、心惊烦躁、身体健康短时失调等亚健康问题越来越严重；而且人口老龄化加快，都市人群精神疲劳等问题日益突出。
谷氨酰胺，学名2-氨基-5-羧基戊酰胺，是谷氨酸的酰胺，L-谷氨酰胺是蛋白质合成中的编码氨基酸，哺乳动物非必需氨基酸，在体内可以由葡萄糖转变而来。谷氨酰胺可用于治疗胃及十二指肠溃疡、胃炎及胃酸过多，也用于改善脑功能。适用人群为：1、少年儿童-促进大脑发育，增强记忆；2、老年人-保持大脑活动，防止老年痴呆症；3、工作繁忙的白领-为大脑充电，防止脑部疲劳；4、病后或手术后需要康复的人士。但是谷氨酰胺不稳定，易变质，水溶性差，人体不易吸收，采用丙谷二肽则可弥补谷氨酰胺的不足，却又不失谷氨酰胺的功能。
发明内容
本发明要解决的技术问题是提供一种含丙谷二肽的饮品组合物，本发明饮品组合物能够补充能量、提高精力、抗衰老、抗疲劳，由氨基酸类、维生素类、添加剂类、微量元素等成分构成，是一种用于调节人体机能的功能性饮品制剂；适合旅游爱好者、运动员、体力劳动和脑力劳动者饮用。
为解决上述技术问题，本发明所采取的技术方案是：一种含丙谷二肽的饮品组合物，原料按重量份包括以下物质：丙谷二肽 0.01～0.9份、蔗糖 15～25份、牛磺酸 0～1.2份、精氨酸门冬氨酸 0～0.6份、赖氨酸盐酸盐 0～0.3份、鸟氨酸盐酸盐 0～0.3份、维生素B3 0～0.25份、维生素B6 0～0.15份、维生素C 0.25～0.4份、维生素B12 0～0.1份、柠檬酸钠 0.1～0.2份、葡萄糖醛酸内酯 0.3～0.6份、氯化钾 0.15～0.3份、DHA 0.06～0.3份、甜味剂 0.2～1.2份。
甜味剂为阿斯巴甜。
原料还包括除甜味剂以外的调味剂、辅料等，还可以包括清茶、纯净水、碳酸饮料或果汁等。
赖氨酸盐酸盐为L-赖氨酸盐酸盐。
丙谷二肽，不仅解决了谷氨酰胺不稳定，水溶性差的问题，而且充分发挥每个单品的功能，形成了对心血管系统、肝脏、肠胃及神经系统的保护。
氨基酸中的门冬氨酸，精氨酸服用后通过三羧酸循环和转氨基作用形成高能量的磷酸化合物，使心肌的摄氧量增加，改善心肌能量代谢，增强耐缺氧作用，调节织物神经功能，减轻冠状动脉压力，缓解胸闷，心律失常等症状。
牛磺酸能明显促进神经系统的生长发育和细胞增殖、分化，提高神经传导和视觉机能，保持人体正常血压对心肌细胞有保护作用，同时能促进垂体激素分泌，活化胰腺功能，改善机体内分泌系统的状态，给机体代谢以有益的调节；并具有促进有机免疫力的增强和抗疲劳的作用。补充适量牛磺酸不仅可以提高记忆力，而且还可以提高记忆的准确性，并且对神经系统的抗衰老也有一定作用。
L-赖氨酸盐酸盐可以提高食物蛋白质的吸收和利用，达到均衡营养，提高智力、促进生长、增强体质，增进食欲、改善营养不良状况，改善失眠，提高记忆力，帮助产生抗体、激素和酶，提高免疫力、增加血色素。
鸟氨酸盐酸盐可以增强人体免疫力，抗除疲劳，有利于人体健康。
维生素B3具有促进消化系统、减轻胃肠障碍；促进血液循环的作用。
维生素B6参与近百种酶反应。参与某些神经介质、核酸和DNA合成，有利于维持适宜的免疫功能。
维生素B12对维护神经系统具有重要作用，能促进碳水化合物、脂肪和蛋白质的代谢，使脂肪、碳水化合物、蛋白质被身体适当运用；同时消除烦躁不安，集中注意力，增强记忆力及平衡感。
葡萄糖醛酸内酯能与体内毒物结合成无毒的葡萄糖醛酸结合物而排出，有护肝解毒作用。
DHA能及时补充达到神经营养，保持健康的工作状态，充分的提高记忆及学习能力，抗衰老、消除疲劳，改善因神经紧张而引起的焦躁、易怒、失眠等症状。
采用上述技术方案所产生的有益效果在于：本发明饮品组合物能够补充能量、提高精力、抗衰老、抗疲劳，由氨基酸类、维生素类、添加剂类、微量元素等成分构成，丙谷二肽性能稳定，不易变质；水溶性好，人体易吸收；是一种用于调节人体机能的功能性饮品制剂；适合旅游爱好者、运动员、体力劳动和脑力劳动者饮用。
具体实施方式
实施例1
一种含丙谷二肽的固体饮品，原料按重量份由以下物质组成：丙谷二肽0.9份、蔗糖 15份、牛磺酸 0.8份、精氨酸门冬氨酸 0.5份、鸟氨酸盐酸盐0.3份、维生素B3 0.1份、维生素B6 0.1份、维生素C 0.4份、维生素B12 0.1份、柠檬酸钠0.2份、葡萄糖醛酸内酯 0.4份、氯化钾0.3份、DHA 0.3份、甜味剂 0.8份；每份为1克。
甜味剂为阿斯巴甜。
具体组成为：丙谷二肽900毫克、蔗糖 15克、牛磺酸 800毫克、精氨酸门冬氨酸 500毫克、鸟氨酸盐酸盐 300毫克、维生素B3 100毫克、维生素B6 100毫克、维生素C 400毫克、维生素B12 100毫克、柠檬酸钠 200毫克、葡萄糖醛酸内酯 400毫克、氯化钾 300毫克、DHA 300毫克、甜味剂 800毫克；将上述原料混合均匀即可。
饮用时将混合均匀的原料置于水杯中，加入常温水300毫升，搅拌使其完全溶解即可饮用。还可以用300mL苹果汁冲饮，也可冷冻。
饮用时还可以加入其他调味品或饮料，如清茶、纯净水、碳酸饮料或果汁等或者直接用上述调味品或饮料冲。适合学生群体饮用，可依个人口味任意比例冲饮。
实施例2
一种含丙谷二肽的固体饮品，原料按重量份由以下物质组成：丙谷二肽 0.6份、蔗糖 15份、牛磺酸 1份、精氨酸门冬氨酸 0.5份、鸟氨酸盐酸盐0.3份、维生素B3 0.05份、维生素B6 0.15份、维生素C 0.4份、维生素B12 0.05份、柠檬酸钠0.2份、葡萄糖醛酸内酯 0.35份、氯化钾0.3份、DHA 0.3份、甜味剂 0.6份；每份为1克。
甜味剂为阿斯巴甜。
具体组成为：丙谷二肽600毫克、蔗糖 15克、牛磺酸 1克、精氨酸门冬氨酸 500毫克、鸟氨酸盐酸盐 300毫克、维生素B3 50毫克、维生素B6 150毫克、维生素C 400毫克、维生素B12 50毫克、柠檬酸钠 200毫克、葡萄糖醛酸内酯 350毫克、氯化钾 300毫克、DHA 300毫克、甜味剂 600毫克；将上述原料混合均匀即可。
饮用时将混合均匀的原料置于水杯中，加入300毫升绿茶，搅拌使其完全溶解即可引用。或者用300mL薄荷茶冲饮。
饮用时还可以加入其他调味品或饮料，如清茶、纯净水、碳酸饮料或果汁等或者直接用上述调味品或饮料冲。适合白领人群饮用，可依个人口味任意比例冲饮。
实施例3
一种含丙谷二肽的固体饮品，原料按重量份由以下物质组成：丙谷二肽0.1份、蔗糖 19.4份、牛磺酸 1.2份、精氨酸门冬氨酸 0.3份、鸟氨酸盐酸盐0.3份、维生素C 0.4份、柠檬酸钠0.2份、葡萄糖醛酸内酯 0.3份、氯化钾0.3份、DHA 0.3份、甜味剂 0.6份；每份为1克。
甜味剂为阿斯巴甜。
具体组成为：丙谷二肽100毫克、蔗糖 19.4克、牛磺酸 1.2克、精氨酸门冬氨酸 300毫克、鸟氨酸盐酸盐 300毫克、维生素C 400毫克、柠檬酸钠200毫克、葡萄糖醛酸内酯 300毫克、氯化钾300毫克、DHA 300毫克、甜味剂 600毫克；每份为1克；将上述原料混合均匀即可。
饮用时将混合均匀的原料置于水杯中，加入冷冻纯净水300毫升，搅拌使其完全溶解即可引用。
饮用时还可以加入其他调味品或饮料，如清茶、纯净水、碳酸饮料或果汁等或者直接用上述调味品或饮料冲。适合运动员饮用，可依个人口味任意比例冲饮。
实施例4
一种含丙谷二肽的固体饮品，原料按重量份由以下物质组成：丙谷二肽 0.3份、蔗糖25份、精氨酸门冬氨酸0.6份、赖氨酸盐酸盐 0.3份、鸟氨酸盐酸盐0.15份、维生素B3 0.25份、维生素B6 0.05份、维生素C 0.25份、柠檬酸钠 0.1份、葡萄糖醛酸内酯0.6份、氯化钾 0.15份、DHA 0.06份、甜味剂 0.2份；每份为1千克。
甜味剂为阿斯巴甜。
具体组成为：丙谷二肽 300克、蔗糖25千克、精氨酸门冬氨酸600克、赖氨酸盐酸盐 300克、鸟氨酸盐酸盐150克、维生素B3 250克、维生素B6 50克、维生素C 250克、柠檬酸钠 100克、葡萄糖醛酸内酯600克、氯化钾 150克、DHA 60克、甜味剂 200克。
饮用时取适量混合均匀的原料置于水杯中，加入常温水，搅拌使其完全溶解即可饮用。还可以用苹果汁冲饮，也可冷冻。
饮用时还可以加入其他调味品或饮料，如清茶、纯净水、碳酸饮料或果汁等或者直接用上述调味品或饮料冲。适合学生群体饮用，可依个人口味任意比例冲饮。
实施例5
一种含丙谷二肽的固体饮品，原料按重量份由以下物质组成：丙谷二肽 0.4份、蔗糖22份、牛磺酸0.5份、精氨酸门冬氨酸0.5份、赖氨酸盐酸盐 0.2份、维生素B3 0.15份、维生素B6 0.07份、维生素C 0.3份、柠檬酸钠 0.15份、葡萄糖醛酸内酯0.5份、氯化钾 0.2份、DHA 0.2份、甜味剂 1.2份；每份为1000千克。
甜味剂为阿斯巴甜。
具体组成为：丙谷二肽 400千克、蔗糖22000千克、牛磺酸500千克、精氨酸门冬氨酸500千克、赖氨酸盐酸盐 200千克、维生素B3 150千克、维生素B6 70千克、维生素C 300千克、柠檬酸钠 150千克、葡萄糖醛酸内酯500千克、氯化钾 200千克、DHA 200千克、甜味剂 1200千克。
饮用时取适量混合均匀的原料置于水杯中，加入常温水，搅拌使其完全溶解即可饮用。还可以用苹果汁冲饮，也可冷冻。
饮用时还可以加入其他调味品或饮料，如清茶、纯净水、碳酸饮料或果汁等或者直接用上述调味品或饮料冲。适合学生群体饮用，可依个人口味任意比例冲饮。
实施例6～14
原料按重量份由以下物质组成，其余参数同实施例1。 
Claims (3)
1.一种含丙谷二肽的固体饮品，其特征在于：原料按重量份包括以下物质：丙谷二肽 0.01～0.9份、蔗糖 15～25份、牛磺酸 0～1.2份、精氨酸门冬氨酸 0～0.6份、赖氨酸盐酸盐 0～0.3份、鸟氨酸盐酸盐 0～0.3份、维生素B3 0～0.25份、维生素B6 0～0.15份、维生素C 0.25～0.4份、维生素B12 0～0.1份、柠檬酸钠 0.1～0.2份、葡萄糖醛酸内酯 0.3～0.6份、氯化钾 0.15～0.3份、DHA 0.06～0.3份、甜味剂 0.2～1.2份。
2.如权利要求1所述的一种含丙谷二肽的固体饮品，其特征在于：所述甜味剂为阿斯巴甜。
3.如权利要求1所述的一种含丙谷二肽的固体饮品，其特征在于：原料还包括除甜味剂以外的调味剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310565995.1A CN103622121B (zh) | 2013-11-13 | 2013-11-13 | 一种含丙谷二肽的固体饮品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310565995.1A CN103622121B (zh) | 2013-11-13 | 2013-11-13 | 一种含丙谷二肽的固体饮品 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103622121A true CN103622121A (zh) | 2014-03-12 |
| CN103622121B CN103622121B (zh) | 2015-09-02 |
Family
ID=50203851
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310565995.1A Active CN103622121B (zh) | 2013-11-13 | 2013-11-13 | 一种含丙谷二肽的固体饮品 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103622121B (zh) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105360847A (zh) * | 2014-09-01 | 2016-03-02 | 山东国际生物科技园发展有限公司 | 一种丙谷二肽保健饮料及其制备方法 |
| CN105661234A (zh) * | 2016-01-22 | 2016-06-15 | 江苏艾兰得营养品有限公司 | 一种迅速恢复体能的饮料及其制备方法 |
| CN107619428A (zh) * | 2017-09-22 | 2018-01-23 | 南京优科生物医药研究有限公司 | 鸟氨酸与门冬氨酸二肽化合物的酰化衍生物及其应用 |
| CN111035017A (zh) * | 2019-12-12 | 2020-04-21 | 山东省药学科学院 | 一种防治肌肉流失的口服液 |
| JP2021050244A (ja) * | 2021-01-07 | 2021-04-01 | 株式会社東洋新薬 | 抗疲労剤 |
| CN113583224A (zh) * | 2021-07-13 | 2021-11-02 | 川北医学院 | Ala-Gln-PPDO/PLGA/PLCA/庆大霉素静电纺丝膜 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070269576A1 (en) * | 2006-05-18 | 2007-11-22 | Brent Barton | Exotic fruit juice and silver-containing beverage |
| CN101248900A (zh) * | 2008-03-28 | 2008-08-27 | 北京东方兴企食品工业技术有限公司 | 一种新型固体运动饮料冲剂 |
| CN101692917A (zh) * | 2009-10-14 | 2010-04-14 | 北京市科威华食品工程技术有限公司 | 脑营养饮料 |
| CN101919801A (zh) * | 2009-07-14 | 2010-12-22 | 无锡健而乐医药科技有限公司 | 口腔吸收固体能量泡腾制剂 |
| CN101982121A (zh) * | 2010-09-19 | 2011-03-02 | 中国科学院广州生物医药与健康研究院 | 一种功能性运动饮料及其制备方法 |
-
2013
- 2013-11-13 CN CN201310565995.1A patent/CN103622121B/zh active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070269576A1 (en) * | 2006-05-18 | 2007-11-22 | Brent Barton | Exotic fruit juice and silver-containing beverage |
| CN101248900A (zh) * | 2008-03-28 | 2008-08-27 | 北京东方兴企食品工业技术有限公司 | 一种新型固体运动饮料冲剂 |
| CN101919801A (zh) * | 2009-07-14 | 2010-12-22 | 无锡健而乐医药科技有限公司 | 口腔吸收固体能量泡腾制剂 |
| CN101692917A (zh) * | 2009-10-14 | 2010-04-14 | 北京市科威华食品工程技术有限公司 | 脑营养饮料 |
| CN101982121A (zh) * | 2010-09-19 | 2011-03-02 | 中国科学院广州生物医药与健康研究院 | 一种功能性运动饮料及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 梁世杰，等: "运动饮料配方设计概论", 《饮料工业》 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105360847A (zh) * | 2014-09-01 | 2016-03-02 | 山东国际生物科技园发展有限公司 | 一种丙谷二肽保健饮料及其制备方法 |
| CN105661234A (zh) * | 2016-01-22 | 2016-06-15 | 江苏艾兰得营养品有限公司 | 一种迅速恢复体能的饮料及其制备方法 |
| CN107619428A (zh) * | 2017-09-22 | 2018-01-23 | 南京优科生物医药研究有限公司 | 鸟氨酸与门冬氨酸二肽化合物的酰化衍生物及其应用 |
| CN107619428B (zh) * | 2017-09-22 | 2020-08-28 | 南京优科生物医药研究有限公司 | 鸟氨酸与门冬氨酸二肽化合物的酰化衍生物及其应用 |
| CN111035017A (zh) * | 2019-12-12 | 2020-04-21 | 山东省药学科学院 | 一种防治肌肉流失的口服液 |
| JP2021050244A (ja) * | 2021-01-07 | 2021-04-01 | 株式会社東洋新薬 | 抗疲労剤 |
| CN113583224A (zh) * | 2021-07-13 | 2021-11-02 | 川北医学院 | Ala-Gln-PPDO/PLGA/PLCA/庆大霉素静电纺丝膜 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103622121B (zh) | 2015-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103622121B (zh) | 一种含丙谷二肽的固体饮品 | |
| US20080233245A1 (en) | Liquid nutrient composition for improving performance | |
| CN112137095A (zh) | 一种运动营养组合物及其制备方法 | |
| WO2006062273A1 (en) | Branched-amino acid supplement food | |
| CN106937743A (zh) | 一种体力恢复剂及其制备方法 | |
| PT102430A (pt) | Metodo aditivo de producao de agua potavel e de bebidas padronizadas a partir de agua (destilada ou desmineralizada) e de bebidas, para perfis de saude | |
| CN101692917B (zh) | 脑营养饮料 | |
| CN105614228A (zh) | 一种藜麦多维营养粉的加工方法 | |
| AU2014292651A1 (en) | Anti-fatigue composition and use thereof | |
| CN110584101A (zh) | 爆珠燕窝、制备方法及饮品 | |
| US20220240558A1 (en) | High-energy food supplement based on inverted sugars and ergogenic products for use in physical activity and method for producing same | |
| RU2428063C1 (ru) | Сухая смесь для спортивного напитка | |
| RU2609813C1 (ru) | Функциональный пищевой продукт "Амино Джем" | |
| US20080038320A1 (en) | Compositions and methods for enhancing vasodilation | |
| CN105533343A (zh) | 一种甜菜根功能性饮料 | |
| CN108697679B (zh) | 含氨基酸的组合物 | |
| CN105341594A (zh) | 一种无糖氨基酸饮料 | |
| CN110771760A (zh) | 一种零色素添加的强化维生素饮料 | |
| CN100393242C (zh) | 一种延年益寿的保健制剂及其制备方法 | |
| Laquale | Red bull: the other energy drink and its effect on performance | |
| RU2579215C1 (ru) | Сухая смесь для приготовления напитка | |
| Sonkeng et al. | Nutritional considerations and dietary supplement use for the performance of professional footballers: A review | |
| CN101904535B (zh) | 多元强化益酒防醉苹果醋功能饮料口服液 | |
| JPS59210871A (ja) | 飲料組成物 | |
| RU2385660C2 (ru) | Концентрат растительный для функционального напитка "казан-бионан-2" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Solid beverage containing N(2)-L-alanyl-L-glutamine Effective date of registration: 20161114 Granted publication date: 20150902 Pledgee: Bank of Beijing Limited by Share Ltd Shijiazhuang branch Pledgor: Jing Jing Pharmaceutical Co., Ltd. Registration number: 2016130000021 |
|
| PLDC | Enforcement, change and cancellation of contracts on pledge of patent right or utility model | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20170323 Granted publication date: 20150902 Pledgee: Bank of Beijing Limited by Share Ltd Shijiazhuang branch Pledgor: Jing Jing Pharmaceutical Co., Ltd. Registration number: 2016130000021 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right |